Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Select Advanced Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04612673
What this trial is testing

A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
China Medical University, China 33
Early research (Phase 1)Study completedNCT05479812
What this trial is testing

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Werewolf Therapeutics, Inc. 156
Testing effectiveness (Phase 2)Looking for participantsNCT06840119
What this trial is testing

Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers

Who this might be right for
CancerHLA-A*02:01-positive
Immunocore Ltd 600
Early research (Phase 1)Study completedNCT00730639
What this trial is testing

Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

Who this might be right for
Metastatic Castration-resistant Prostrate CancerRenal Cell CarcinomaMetastatic Melanoma+1 more
Bristol-Myers Squibb 395
Large-scale testing (Phase 3)Not Yet RecruitingNCT07689539
What this trial is testing

Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation

Who this might be right for
Pancreatic Cancer
Jiangxi Kvvit Pharmaceutical Co., Ltd. 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT05189730
What this trial is testing

Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute 80
Early research (Phase 1)Looking for participantsNCT07414836
What this trial is testing

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 84
Early research (Phase 1)Study completedNCT04943900
What this trial is testing

BMS-986416 With and Without Nivolumab in Select Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 67
Testing effectiveness (Phase 2)Study completedNCT03070392
What this trial is testing

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

Who this might be right for
Uveal Melanoma
Immunocore Ltd 378
Early research (Phase 1)Looking for participantsNCT07166601
What this trial is testing

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 77
Early research (Phase 1)UnknownNCT03710265
What this trial is testing

SHR-1701 in Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jiangsu HengRui Medicine Co., Ltd. 206